Amino
Amino Health, now known as Judi Care, offers a healthcare navigation platform to help users find affordable, in-network providers.
Secondary Market Price
How Amino Measures Up
To help you manage your Amino equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series C
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Amino's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Amino Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Amino's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Judi Care, formerly known as Amino Health, operates a data-driven healthcare navigation platform. The company partners with health plans, third-party administrators (TPAs), and benefits platforms to provide members with personalized care recommendations and guidance to in-network providers. Its platform offers features such as proprietary cost and quality ratings, encounter-level cost estimates, and support for incentive programs. Founded in 2013, the company has processed 19 billion medical claims as of March 2024 and has raised a total of $45 million in funding.
In 2025, Amino Health was acquired by Judi Health and subsequently rebranded as Judi Care. This acquisition included the integration of a technology that enables health plans to launch dynamic co-pay products. That same year, the company launched its Unified Claims Processing™ platform and was recognized as a Deloitte Technology Fast 500 winner for the fourth consecutive year. The company has indicated plans for continued expansion of its Health Benefits Platform, which includes pharmacy management, claims processing, and care navigation, with a focus on technology-driven healthcare solutions.
- GV
- Venrock
- Union Square Ventures
- Box Group
- Time Warner Investments
- Goodwater Capital
- Hearst Ventures
- Co-Founder, Ben Anderson
- Co-Founder, Yin Wang
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Amino worth joining?
Deciding to join a startup like Amino involves assessing the company's potential and how its equity package aligns with your financial goals. Tools like Prospect can help you model the future value of your equity and make a more informed decision.
What should I do with my Amino stock?
The right strategy for your Amino stock depends on your personal financial goals, tax situation, and risk tolerance. Platforms like Prospect can build a customized plan for exercising options and selling shares to maximize your after-tax returns.
Can you sell Amino stock?
As Amino is a private company, you can typically sell shares through secondary markets or during company-approved tender offers. Platforms like Prospect provide Tender Offer Tools that help you decide how much to sell and which shares are tax-optimal.
How can I find the value of my Amino stock?
The value of private stock like Amino's is not publicly listed and is formally determined by a 409A valuation, but its future worth can vary significantly. You can use Prospect’s predictive models, which are trained on venture capital data, to project the future value of your shares.
What is Amino's equity worth?
Since Amino is a private company, its equity doesn't have a publicly traded market price, and its value depends on factors like the latest valuation and future growth. A platform like Prospect can help you understand the potential post-tax value of your specific holdings by creating a personalized financial model.
What is Amino's stock ticker symbol?
As a private company, Amino does not have a stock ticker symbol because its shares are not traded on a public stock exchange. Ticker symbols are assigned to companies only when they become publicly listed through an Initial Public Offering (IPO).
Can I buy or sell Amino stock?
Selling private Amino stock is often possible through secondary markets, while buying opportunities are typically limited to accredited investors or specific funding rounds. If you are considering selling, Prospect provides tools to help you decide when to sell and which shares to sell for optimal tax outcomes.
What is the criteria to buy or invest in Amino stock?
Investing in a private company like Amino is typically restricted to accredited investors who meet specific income or net worth thresholds defined by financial regulators. Opportunities may also arise through venture capital funds or if you are an employee receiving equity as part of your compensation.
